Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 4

1(20.0%)

Phase 2

1(20.0%)

5Total

N/A(3)

Phase 4(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT04479618Not ApplicableCompleted

Test of the Safety, Effectiveness, & Acceptability of An Improvised Dressing for Sickle Cell Leg Ulcers in the Tropics

Role: collaborator

NCT03449940Not ApplicableCompleted

Penile Fracture: A Comparison of Erectile Function After Immediate Repair Versus Delayed Repair

Role: collaborator

NCT01700478Phase 4Completed

Study of the Use of Misoprostol to Decrease Bleeding During a Myomectomy

Role: lead

NCT00818935Not ApplicableCompleted

Low-Intermediate-Glycemic Index Caribbean Foods Versus High Glycemic Index Foods in Type 2 Diabetes

Role: lead

NCT00409890Phase 2Completed

The Effect of Hyoscine Butyl Bromide on the First Stage of Labor in Term Pregnancies

Role: lead

All 5 trials loaded